UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:HSD17B12-WT1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: HSD17B12-WT1 | FusionPDB ID: 37666 | FusionGDB2.0 ID: 37666 | Hgene | Tgene | Gene symbol | HSD17B12 | WT1 | Gene ID | 51144 | 7490 |
Gene name | hydroxysteroid 17-beta dehydrogenase 12 | WT1 transcription factor | |
Synonyms | KAR|SDR12C1 | AWT1|GUD|NPHS4|WAGR|WIT-2|WT33 | |
Cytomap | 11p11.2 | 11p13 | |
Type of gene | protein-coding | protein-coding | |
Description | very-long-chain 3-oxoacyl-CoA reductase17-beta-HSD 1217-beta-hydroxysteroid dehydrogenase 1217beta-HSD type 123-ketoacyl-CoA reductaseestradiol 17-beta-dehydrogenase 12short chain dehydrogenase/reductase family 12C member 1steroid dehydrogenase hom | Wilms tumor proteinWilms tumor 1 | |
Modification date | 20200313 | 20200320 | |
UniProtAcc | Q53GQ0 | P19544 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000278353, ENST00000395700, ENST00000529261, | ENST00000332351, ENST00000379079, ENST00000448076, ENST00000530998, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 13 X 13 X 7=1183 | 3 X 6 X 5=90 |
# samples | 14 | 4 | |
** MAII score | log2(14/1183*10)=-3.07895134139482 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/90*10)=-1.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: HSD17B12 [Title/Abstract] AND WT1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | HSD17B12(43702537)-WT1(32450165), # samples:4 | ||
Anticipated loss of major functional domain due to fusion event. | HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | WT1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 7585606 |
Tgene | WT1 | GO:0007530 | sex determination | 9815658 |
Tgene | WT1 | GO:0008285 | negative regulation of cell proliferation | 9553041|9765217 |
Tgene | WT1 | GO:0030308 | negative regulation of cell growth | 9553041|9765217 |
Tgene | WT1 | GO:0045892 | negative regulation of transcription, DNA-templated | 1332065|7585606|7720589|8119964|12802290|14701728|19050011 |
Tgene | WT1 | GO:0045893 | positive regulation of transcription, DNA-templated | 8132626|9178767|9553041|9765217|12802290|14701728|16467207|21390327 |
Tgene | WT1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 23042785 |
Tgene | WT1 | GO:0071371 | cellular response to gonadotropin stimulus | 15961562 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | KICH | TCGA-KL-8335-01A | HSD17B12 | chr11 | 43702537 | - | WT1 | chr11 | 32450165 | - |
ChimerDB4 | KICH | TCGA-KL-8335-01A | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - |
ChimerDB4 | KICH | TCGA-KL-8335 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000379079 | WT1 | chr11 | 32450165 | - | 2461 | 279 | 119 | 1177 | 352 |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000332351 | WT1 | chr11 | 32450165 | - | 2470 | 279 | 119 | 1186 | 355 |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000530998 | WT1 | chr11 | 32450165 | - | 2416 | 279 | 119 | 1135 | 338 |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000448076 | WT1 | chr11 | 32450165 | - | 1557 | 279 | 119 | 1177 | 352 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000379079 | WT1 | chr11 | 32450165 | - | 2389 | 207 | 47 | 1105 | 352 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000332351 | WT1 | chr11 | 32450165 | - | 2398 | 207 | 47 | 1114 | 355 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000530998 | WT1 | chr11 | 32450165 | - | 2344 | 207 | 47 | 1063 | 338 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000448076 | WT1 | chr11 | 32450165 | - | 1485 | 207 | 47 | 1105 | 352 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000278353 | ENST00000379079 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015225739 | 0.98477423 |
ENST00000278353 | ENST00000332351 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015108737 | 0.98489124 |
ENST00000278353 | ENST00000530998 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.009088906 | 0.99091107 |
ENST00000278353 | ENST00000448076 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.11383599 | 0.88616407 |
ENST00000395700 | ENST00000379079 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015235038 | 0.98476493 |
ENST00000395700 | ENST00000332351 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015001932 | 0.98499805 |
ENST00000395700 | ENST00000530998 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.008630293 | 0.9913697 |
ENST00000395700 | ENST00000448076 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.103710964 | 0.896289 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >37666_37666_1_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000332351_length(amino acids)=355AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_2_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000379079_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_3_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000448076_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_4_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000530998_length(amino acids)=338AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGHSTGYESDNHTTPILCGAQYRIHTH GVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVK -------------------------------------------------------------- >37666_37666_5_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000332351_length(amino acids)=355AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_6_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000379079_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_7_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000448076_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_8_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000530998_length(amino acids)=338AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGHSTGYESDNHTTPILCGAQYRIHTH GVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:43702537/chr11:32450165) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
HSD17B12 | WT1 |
FUNCTION: Catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate in the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation. {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16166196}. | FUNCTION: Transcription factor that plays an important role in cellular development and cell survival (PubMed:7862533). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3' (PubMed:7862533, PubMed:17716689, PubMed:25258363). Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors (PubMed:15520190). Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing (PubMed:16934801). Isoform 1 has lower affinity for DNA, and can bind RNA (PubMed:19123921). {ECO:0000269|PubMed:15520190, ECO:0000269|PubMed:16934801, ECO:0000269|PubMed:17716689, ECO:0000269|PubMed:19123921, ECO:0000269|PubMed:19416806, ECO:0000269|PubMed:25258363, ECO:0000269|PubMed:7862533}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 4_24 | 53.333333333333336 | 313.0 | Transmembrane | Helical |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 27_83 | 3.3333333333333335 | 303.0 | Compositional bias | Note=Pro-rich | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 27_83 | 3.3333333333333335 | 289.0 | Compositional bias | Note=Pro-rich | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 236_244 | 3.3333333333333335 | 303.0 | Motif | 9aaTAD | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 236_244 | 3.3333333333333335 | 289.0 | Motif | 9aaTAD | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 323_347 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 1 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 353_377 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 2 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 383_405 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 3 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 414_438 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 4 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 323_347 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 1 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 353_377 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 2 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 383_405 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 3 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 414_438 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 4 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 308_312 | 53.333333333333336 | 313.0 | Motif | Note=Di-lysine motif |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 50_79 | 53.333333333333336 | 313.0 | Nucleotide binding | NADP |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 182_202 | 53.333333333333336 | 313.0 | Transmembrane | Helical |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 271_291 | 53.333333333333336 | 313.0 | Transmembrane | Helical |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>694_HSD17B12_43702537_WT1_32450165_ranked_0.pdb | HSD17B12 | 43702537 | 43702537 | ENST00000448076 | WT1 | chr11 | 32450165 | - | MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF | 355 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
HSD17B12_pLDDT.png![]() |
WT1_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
HSD17B12 | |
WT1 | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to HSD17B12-WT1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to HSD17B12-WT1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | WT1 | C0950121 | Denys-Drash Syndrome | 20 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C0027708 | Nephroblastoma | 8 | CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C3151568 | NEPHROTIC SYNDROME, TYPE 4 | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | WT1 | C0950122 | Frasier Syndrome | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C1837026 | MEACHAM SYNDROME (disorder) | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C0023467 | Leukemia, Myelocytic, Acute | 2 | CGI;CTD_human |
Tgene | WT1 | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Tgene | WT1 | C0345967 | Malignant mesothelioma | 2 | CTD_human;GENOMICS_ENGLAND |
Tgene | WT1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Tgene | WT1 | C2930471 | Bilateral Wilms Tumor | 2 | CTD_human |
Tgene | WT1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | WT1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Tgene | WT1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Tgene | WT1 | C0017636 | Glioblastoma | 1 | CTD_human |
Tgene | WT1 | C0017658 | Glomerulonephritis | 1 | CTD_human |
Tgene | WT1 | C0018054 | Gonadal Dysgenesis, 46,XY | 1 | ORPHANET |
Tgene | WT1 | C0019284 | Diaphragmatic Hernia | 1 | CTD_human |
Tgene | WT1 | C0023418 | leukemia | 1 | CTD_human |
Tgene | WT1 | C0023473 | Myeloid Leukemia, Chronic | 1 | CTD_human |
Tgene | WT1 | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human |
Tgene | WT1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | WT1 | C0027809 | Neurilemmoma | 1 | CTD_human |
Tgene | WT1 | C0029463 | Osteosarcoma | 1 | CTD_human |
Tgene | WT1 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Tgene | WT1 | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
Tgene | WT1 | C0085215 | Ovarian Failure, Premature | 1 | CTD_human |
Tgene | WT1 | C0086367 | Gonadotropin-Resistant Ovary Syndrome | 1 | CTD_human |
Tgene | WT1 | C0206115 | WAGR Syndrome | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | WT1 | C0235833 | Congenital diaphragmatic hernia | 1 | CTD_human |
Tgene | WT1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Tgene | WT1 | C0265699 | Congenital hernia of foramen of Morgagni | 1 | CTD_human |
Tgene | WT1 | C0265700 | Congenital hernia of foramen of Bochdalek | 1 | CTD_human |
Tgene | WT1 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Tgene | WT1 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Tgene | WT1 | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human |
Tgene | WT1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | WT1 | C0751374 | Schwannomatosis, Plexiform | 1 | CTD_human |
Tgene | WT1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | WT1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | WT1 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Tgene | WT1 | C1704377 | Bright Disease | 1 | CTD_human |
Tgene | WT1 | C1840452 | Hyaloideoretinal degeneration of Wagner | 1 | GENOMICS_ENGLAND |
Tgene | WT1 | C1868672 | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1 | ORPHANET |
Tgene | WT1 | C2931803 | Deletion 11p13 | 1 | ORPHANET |
Tgene | WT1 | C2936694 | Swyer Syndrome | 1 | ORPHANET |
Tgene | WT1 | C3494522 | Hypergonadotropic Ovarian Failure, X-Linked | 1 | CTD_human |
Tgene | WT1 | C4510744 | 46,XY partial gonadal dysgenesis | 1 | ORPHANET |
Tgene | WT1 | C4552079 | Premature Ovarian Failure 1 | 1 | CTD_human |
Tgene | WT1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |